NCT00376974

Brief Summary

With patient education, the compliance with glaucoma medications will increase.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2005

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2005

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2006

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 15, 2006

Completed
Last Updated

September 15, 2006

Status Verified

September 1, 2006

First QC Date

September 13, 2006

Last Update Submit

September 13, 2006

Conditions

Glaucoma

Keywords

glaucomacomplianceintraocular pressurevideo

Outcome Measures

Primary Outcomes (1)

  • Intraocular pressure

Secondary Outcomes (1)

  • Score on glaucoma educational test

Interventions

American Academy of Ophthalmology Glaucoma Educational TapeBEHAVIORAL

Eligibility Criteria

Age40 Years - 90 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Glaucoma patients coming in for routine examination

You may not qualify if:

  • If glaucoma was unstable and treatment regimen required a change

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MDVAMC

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

GlaucomaPatient Compliance

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Silvia Orengo-Nania, m.d.

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
ECT
Intervention Model
PARALLEL
Sponsor Type
FED

Study Record Dates

First Submitted

September 13, 2006

First Posted

September 15, 2006

Study Start

March 1, 2005

Study Completion

May 1, 2006

Last Updated

September 15, 2006

Record last verified: 2006-09

Locations

US(1)